Keros Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Keros Therapeutics, Inc. (KROS) reported Earnings Per Share, Basic and Diluted of -$0.68 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-06
- Keros Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.68.
- Keros Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.45.
- Keros Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.60.
- Keros Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.62.
- Keros Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.93.
- Keros Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$6.08.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$0.68 10-Q · filed 2021-05-06 | -$1.14 derived: net income ÷ weighted average shares · filed 2022-05-05 | -$1.73 derived: net income ÷ weighted average shares · filed 2022-05-05 | -$2.35 derived: net income ÷ weighted average shares · filed 2022-05-05 |
| 2020-12-31 | -$0.45 derived: net income ÷ weighted average shares · filed 2022-03-09 | -$1.04 derived: net income ÷ weighted average shares · filed 2022-03-09 | -$1.65 derived: net income ÷ weighted average shares · filed 2022-03-09 | -$2.93 10-K · filed 2021-03-25 |
| 2020-09-30 | -$0.60 10-Q · filed 2020-11-10 | -$1.22 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$2.65 10-Q · filed 2020-11-10 | -$3.64 derived: net income ÷ weighted average shares · filed 2021-11-04 |
| 2020-06-30 | -$0.62 10-Q · filed 2020-08-13 | -$2.35 10-Q · filed 2020-08-13 | -$3.58 derived: net income ÷ weighted average shares · filed 2021-08-05 | -$4.96 derived: net income ÷ weighted average shares · filed 2021-08-05 |
| 2020-03-31 | -$5.11 10-Q · filed 2021-05-06 | -$6.49 derived: net income ÷ weighted average shares · filed 2021-05-06 | -$8.24 derived: net income ÷ weighted average shares · filed 2021-05-06 | -$9.74 derived: net income ÷ weighted average shares · filed 2021-05-06 |
| 2019-12-31 | -$1.32 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$3.03 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$4.47 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$6.08 10-K · filed 2021-03-25 |
| 2019-09-30 | -$1.71 10-Q · filed 2020-11-10 | -$3.15 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$4.76 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$1.44 10-Q · filed 2020-08-13 | -$3.05 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | -$1.61 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |